Moser Wealth Advisors »

Crispr Therapeutics shares owned by Moser Wealth Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Moser Wealth Advisors from 13F filings

Historical chart of Moser Wealth Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Moser Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Moser Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 200 68.16
2023-12-31 $13k 200 62.60
2023-09-30 $9.1k 200 45.39
2023-06-30 $11k 200 56.14
2022-12-31 $8.1k 200 40.65
2022-09-30 $3.0k 50 60.00
2022-06-30 $3.0k 50 60.00
2022-03-31 $3.0k 50 60.00
2021-12-31 $4.0k 50 80.00
2021-09-30 $6.0k 50 120.00